24 Stocks Moving in Thursday's Pre-Market Session

Gainers

• Amplitude Healthcare Acquisition Corporation AMHC rose 61.8% to $16.55 in pre-market trading. The company disclosed that shareholders approved the business combination with Jasper Therapeutics.
• MEDIROM Healthcare Technologies Inc. MRM rose 37.4% to $10.15 in pre-market trading following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
• Digital Brands Group, Inc. DBGI rose 21.3% to $2.95 in pre-market trading. Digital Brands Group, last month, highlighted completion of Stateside acquisition.
• Puxin Limited NEW rose 14.6% to $0.55 in pre-market trading after gaining over 6% on Wednesday.
• Solid Biosciences Inc. SLDB rose 12.7% to $3.38 in pre-market trading after dropping over 6% on Wednesday.
• Regencell Bioscience Holdings Limited RGC rose 11.7% to $23.06 in pre-market trading after jumping over 25% on Wednesday. Regencell Bioscience's subsidiary in Hong Kong recently entered into a joint venture agreement with Honor Epic Enterprises Limited to offer COVID-19 related treatments.
• Matinas BioPharma Holdings, Inc. MTNB rose 9.5% to $1.50 in pre-market trading after jumping 17% on Wednesday. The company recently announced data in the ongoing EnACT trial of MAT2203 for treatment of cryptococcal meningitis.
• BlackBerry Limited BB rose 9.3% to $10.46 in pre-market trading. BlackBerry reported a narrower-than-expected loss for its second quarter, while sales exceeded estimates.
• Northern Dynasty Minerals Ltd. NAK rose 9% to $0.51 in pre-market trading.
• Camber Energy, Inc. CEI shares rose 8.8% to $1.59 in pre-market trading after dropping 9% on Wednesday.
• PAVmed Inc. PAVM rose 7.9% to $8.86 in pre-market trading.
• BEST Inc. BEST rose 7.7% to $1.82 in pre-market trading after gaining around 4% on Wednesday.
• China Liberal Education Holdings Limited CLEU shares rose 7.1% to $3.19 in pre-market trading after gaining over 3% on Wednesday.
• Greenpro Capital Corp. GRNQ rose 7.4% to $0.67 in pre-market trading. The company recently said it is investing in two STO projects approved by CEZA on CryptoSX platform.
• Senmiao Technology Limited AIHS rose 7.1% to $0.76 in pre-market trading after jumping 26% on Wednesday.
• Valneva SE VALN rose 7% to $33.66 in pre-market trading after the company continued expansion of clinical trials of its inactivated COVID-19 vaccine candidate VLA2001.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Eargo, Inc. EAR shares fell 57.1% to $9.29 in pre-market trading fter the company disclosed it was the target of a Dept. of Justice criminal investigation. The company also withdrew its FY21 guidance. JP Morgan and Wells Fargo also downgraded the stock.
• Magal Security Systems Ltd. MAGS fell 29.9% to $3.83 in pre-market trading.
• Aethlon Medical, Inc. AEMD fell 8.5% to $4.63 in pre-market trading after jumping over 33% on Wednesday.
• Vale S.A. VALE shares fell 8.3% to $15.06 in pre-market trading. B of A Securities yesterday downgraded Vale from Buy to Neutral and lowered the price target from $27 to $20.
• Synlogic, Inc. SYBX shares fell 8.3% to $3.20 in pre-market trading after the company priced its 15 million share public offering of common stock at $3.00 per share.
• Marin Software Incorporated MRIN fell 7.7% to $8.50 in pre-market trading. Marin Software shares jumped around 62% on Wednesday following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products.
• Ensysce Biosciences, Inc. ENSC fell 6.3% to $4.04 in pre-market trading after dropping over 5% on Wednesday.
• Onconova Therapeutics, Inc. ONTX shares fell 5.7% to $5.94 in pre-market trading. Onconova Therapeutics shares jumped over 28% on Wednesday after the company reported preliminary data from a Phase 1/2 a trial of rigosertib plus immune checkpoint inhibitor nivolumab, which are being presented at the 3rd Annual RAS Targeted Drug Development Summit.